Press Releases for EURX

Press Releases
Eurand Announces Pricing of Offering of Ordinary Shares
Ingenico Announces the Acquisition of Easycash, a Leading Payment Services Provider Based in Germany
Eurand to Participate in Upcoming Investor Conferences
Eurand Reports Recent Developments and Second Quarter 2009 Financial Results
Eurand Successfully Completes Registration Procedure for Paracetamol ODT 250 and 500 mg in the European Union
Eurand Announces Conference Call on Second Quarter 2009 Financial Results
FDA Extends Review Period for Eurand's ZENPEP(TM) Pancreatic Enzyme Replacement Therapy
Eurand to Present at UBS Global Specialty Pharmaceuticals Conference in London
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Eurand Reports Recent Highlights and First Quarter 2009 Financial Results
Eurand to Present at Upcoming Investor Conferences
Eurand Announces Conference Call on First Quarter 2009 Financial Results
Eurand Announces International Agreements for Once-Daily Extended Release Muscle Relaxant - Market Wire
Zacks Bull & Bear of the Day Highlights: Kroger, Carmax, Eastman Chemical, ABM Industries and Eurand N.V.
FDA Grants Orphan Drug Designation for EUR-1073
Eurand Reports Recent Developments and Fourth Quarter and Full-Year 2008 Financial Results
Eurand to Present at Cowen Health Care Conference
Eurand to Present at Barclays Capital Global Healthcare Conference
Eurand Announces Conference Call on Fourth Quarter and Full-Year 2008 Financial Results
/ CORRECTION - Eurand to Present at Deutsche Bank Securities Small- and Mid-Cap Conference
Eurand to Present at Deutsche Bank Securities Small- and Mid-Cap Conference
FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete
FDA Issues Complete Response Letter to GlaxoSmithKline for Eurand's EUR-1048
Eurand's Raw Material Supplier Submits Response to FDA for DMF-Related Questions On EUR-1008 (ZENTASE(r))
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Eurand Appoints Dr. Ruth Thieroff-Ekerdt as Chief Medical Officer
Eurand to Present At Lazard Capital Markets 5th Annual Healthcare Conference
Zacks Analyst Blog Highlights: Sprint Nextel Corp., Ultrapar Participacoes SA, Eurand N.V., Cephalon, Inc. And GlaxoSmithKline Inc.
Eurand Reports Recent Developments and Third Quarter and Year-to-Date 2008 Financial Results
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
Eurand Announces Conference Call On Third Quarter 2008 Financial Results
Eurand Provides Update On EUR-1008 (ZENTASE)
Eurand to Present At Thomas Weisel Partners Healthcare Conference 2008
Zacks Analyst Blog Highlights: Comerica Inc., Advance Auto Parts, Inc., Eurand N.V., Cephalon Inc. And GlaxoSmithKline Plc.
Eurand Reports Recent Developments and Second Quarter 2008 Financial Results
Eurand to Receive $35 Million Payment in Litigation Settlement
Eurand to Receive $35 Million Payment and Litigation Settlement
Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd (South Korea) for Once-Daily Extended Release Muscle Relaxant
Eurand Announces Conference Call On Second Quarter 2008 Financial Results
Eurand Industrial Award Honors Achievement in Drug Delivery Research
Eurand Names Bill Newbould Vice President, Investor Relations
Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)
Eurand to Be Issued U.S. Patent for Amrix(r)
Eurand to Present At UBS Global Specialty and Generic Pharmaceuticals Conference - May 27 2008 12:57AM
Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008
Eurand Reports First Quarter 2008 Key Achievements and Financial Results
Eurand to Present At Upcoming Conferences
Eurand Announces Launch of OTC Unisom SleepMelts by Chattem
Eurand Announces EUR-1008 (Zentase) Eligibility for European Centralized Review
Eurand Announces First Quarter 2008 Financial Results Conference Call
Eurand in Licenses Corticosteroid GI Product From Chiesi Farmaceutici SpA
Eurand Receives a Notice of Allowance for U.S. Patent Application Covering Amrix